Rebecca Hui Min Hoe, Fan Yang, Siew Kit Shuit, Glenn Khai Wern Yong, Ser Hon Puah, Jennifer Sye Jin Ting, Mucheli Sharavan Sadasiv, Thirugnanam Umapathi
J Mov Disord. 2023;16(2):217-220. Published online April 26, 2023
Efficacy of telerehabilitation with digital and robotic tools for the continuity of care of people with chronic neurological disorders: The TELENEURO@REHAB protocol for a randomized controlled trial Federica Rossetto, Fabiola Giovanna Mestanza Mattos, Elisa Gervasoni, Marco Germanotta, Arianna Pavan, Davide Cattaneo, Irene Aprile, Francesca Baglio DIGITAL HEALTH.2024;[Epub] CrossRef
The Last Straw: How Stress Can Unmask Parkinson’s Disease Anouk van der Heide, Claudia Trenkwalder, Bastiaan R. Bloem, Rick C. Helmich Journal of Parkinson's Disease.2024; 14(4): 889. CrossRef
SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now Iro Boura, Mubasher A. Qamar, Francesco Daddoveri, Valentina Leta, Karolina Poplawska-Domaszewicz, Cristian Falup-Pecurariu, K. Ray Chaudhuri Biomedicines.2023; 11(9): 2524. CrossRef
Defining the Clinicoradiologic Syndrome of SARS-CoV-2 Acute Necrotizing Encephalopathy Vanessa W. Lee, Kai Qian Kam, Ahmad R. Mohamed, Husna Musa, Poorani Anandakrishnan, Qingtang Shen, Alexander F. Palazzo, Russell C. Dale, Ming Lim, Terrence Thomas Neurology Neuroimmunology & Neuroinflammation.2024;[Epub] CrossRef
Post-COVID parkinsonism: A scoping review Paola Polverino, Antoniangela Cocco, Alberto Albanese Parkinsonism & Related Disorders.2024; 123: 106066. CrossRef
Bilateral thalamic glioblastoma presenting as parkinsonism: A case report Daniel Mareček, Viktorie Kopecká, Radoslav Matěj, Ondřej Strýček Parkinsonism & Related Disorders.2024; 128: 107147. CrossRef
Steroid administration for post‐COVID‐19 Parkinsonism: A case report Witoon Mitarnun, Metha Apiwattanakul, Thanatchanan Thodthasri, Praewa Tantisungvarakoon, Wilasinee Pangwong Neurology and Clinical Neuroscience.2023; 11(1): 49. CrossRef
Movement Disorders andSARS‐CoV‐2 Wilson K.W. Fung, Alfonso Fasano, Conor Fearon Movement Disorders Clinical Practice.2023;[Epub] CrossRef
Myorhythmia and Other Movement Disorders in Two Patients With Coronavirus Disease 2019 Encephalopathy Rebecca Hui Min Hoe, Fan Yang, Siew Kit Shuit, Glenn Khai Wern Yong, Ser Hon Puah, Jennifer Sye Jin Ting, Mucheli Sharavan Sadasiv, Thirugnanam Umapathi Journal of Movement Disorders.2023; 16(2): 217. CrossRef
Limb myorhythmia treated with chemodenervation: a case report Nil Saez-Calveras, Meredith Bryarly, Meagen Salinas Therapeutic Advances in Neurological Disorders.2023;[Epub] CrossRef
Acute Necrotizing Encephalopathy in Adult Patients With COVID-19: A Systematic Review of Case Reports and Case Series Shaghayegh Karami, Fattaneh Khalaj, Houman Sotoudeh, Zohreh Tajabadi, Ramin Shahidi, Mohammad Amin Habibi, Mahsa Shirforoush Sattari, Amir Azimi, Seyed Ali Forouzannia, Romina Rafiei, Hamid Reihani, Reza Nemati, Soraya Teimori, Amirmohammad Khalaji, Vida Journal of Clinical Neurology.2023; 19(6): 597. CrossRef
Parkinson’s Disease in Light of the COVID-19 Pandemic Anna Drelich-Zbroja, Mateusz Cheda, Maryla Kuczyńska, Izabela Dąbrowska, Ewa Kopyto, Izabela Halczuk Brain Sciences.2022; 12(2): 143. CrossRef
Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review Jeremy M. Morowitz, Kaylyn B. Pogson, Daniel A. Roque, Frank C. Church Brain Sciences.2022; 12(5): 536. CrossRef
Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far Iro Boura, Kallol Ray Chaudhuri Movement Disorders Clinical Practice.2022; 9(5): 584. CrossRef
COVID-19 and Parkinsonism: A Critical Appraisal Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, Eleonora Del Prete, Sara Meoni, Sara Grisanti, Marialuisa Zedde, Rosario Pascarella, Elena Moro, Franco Valzania Biomolecules.2022; 12(7): 970. CrossRef
Viruses, parkinsonism and Parkinson’s disease: the past, present and future Valentina Leta, Daniele Urso, Lucia Batzu, Yue Hui Lau, Donna Mathew, Iro Boura, Vanessa Raeder, Cristian Falup-Pecurariu, Daniel van Wamelen, K. Ray Chaudhuri Journal of Neural Transmission.2022; 129(9): 1119. CrossRef
There is an extensive debate on the neurological consequences of 2019 novel coronavirus disease (COVID-19) and its impact on Parkinson’s disease (PD) patients, which seems to puzzle neurologists. Links between viral infections and PD have long been suspected and studied, but the exact relationship remains elusive. Since severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) enters the brain through multiple routes and has a direct impact on the brain, cumulative damage occurs due to the activation of proinflammatory cytokines and chemokines. SARS-CoV-2 seems to aggravate PD due to its effects on α-synuclein, mitochondrial dysfunction, and dopamine depletion. A few studies have even highlighted the higher vulnerability of PD patients to COVID-19. The sudden dramatic change in lifestyle caused by the pandemic and the widespread lockdowns that were implemented have added to the hidden sorrows of PD patients, as they already have a compromised mechanism for coping with stress. This review summarizes insights from basic science and the clinical effect of SARS-CoV-2 infection on the human brain, with a specific focus on PD.
Citations
Citations to this article as recorded by
Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID‐19 infection Yousef Rasmi, Ameneh Shokati, Shima Hatamkhani, Yeganeh Farnamian, Roya Naderi, Ladan Jalali Reviews in Medical Virology.2024;[Epub] CrossRef
SARS-CoV-2 Infection to Premature Neuronal Aging and
Neurodegenerative Diseases: Is there any Connection with Hypoxia? Narmadhaa Sivagurunathan, Latchoumycandane Calivarathan CNS & Neurological Disorders - Drug Targets.2024; 23(4): 431. CrossRef
Deciphering the molecular pathways underlying dopaminergic neuronal damage in Parkinson's disease associated with SARS-CoV-2 infection Qiuhan Xu, Sisi Jiang, Ruiqing Kang, Yiling Wang, Baorong Zhang, Jun Tian Computers in Biology and Medicine.2024; 171: 108200. CrossRef
Headache and Dizziness as Prevailing Clinical Manifestations in Parkinson's Patients Following COVID-19 Mohammad Haddadi, Yasamin Meamarzadegan, Ali Vasheghani Farahani, Alireza Etrati Kooshali, Sheida Sarrafzadeh, Parsa Ghafari, Parsa Nobaveh, Omid Salahi Ardekani, Zahra Taghiabadi, Saeed Motlaghzadeh, Sepehr Damghani, Arash Letafati Archives of Neuroscience.2024;[Epub] CrossRef
Brain-Region-Specific Differences in Protein Citrullination/Deimination in a Pre-Motor Parkinson’s Disease Rat Model Audrey Mercer, Marco Sancandi, Amy Maclatchy, Sigrun Lange International Journal of Molecular Sciences.2024; 25(20): 11168. CrossRef
Axial Improvement after Casirivimab/Imdevimab Treatment for COVID-19 in Parkinson’s Disease Valentina Fioravanti, Francesco Cavallieri, Alessio Di Fonzo, Giulia Toschi, Sara Grisanti, Gaetano Salomone, Mario Zappia, Franco Valzania Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2023; 50(5): 777. CrossRef
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms Pei Huang, Lin-Yuan Zhang, Yu-Yan Tan, Sheng-Di Chen Translational Neurodegeneration.2023;[Epub] CrossRef
Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All? Yulia Stroylova, Anastasiia Konstantinova, Victor Stroylov, Ivan Katrukha, Fedor Rozov, Vladimir Muronetz Biomedicines.2023; 11(2): 498. CrossRef
Sex and age affect acute and persisting COVID-19 illness Anna Vasilevskaya, Asma Mushtaque, Michelle Y. Tsang, Batoul Alwazan, Margaret Herridge, Angela M. Cheung, Maria Carmela Tartaglia Scientific Reports.2023;[Epub] CrossRef
Vulnerability of Parkinson’s Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review Sorayya Rezayi, Meysam Rahmani Katigari, Leila Shahmoradi, Mehrbakhsh Nilashi, Hélio Teive Parkinson's Disease.2023; 2023: 1. CrossRef
COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent Sebastián García Menéndez, Virna Margarita Martín Giménez, Michael F. Holick, Francisco J. Barrantes, Walter Manucha Life Sciences.2022; 297: 120464. CrossRef
SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro Zhengcun Wu, Xiuao Zhang, Zhangqiong Huang, Kaili Ma International Journal of Molecular Sciences.2022; 23(6): 3394. CrossRef
COVID-19 and Parkinsonism: A Critical Appraisal Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, Eleonora Del Prete, Sara Meoni, Sara Grisanti, Marialuisa Zedde, Rosario Pascarella, Elena Moro, Franco Valzania Biomolecules.2022; 12(7): 970. CrossRef
SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response Pi-Ching Hsu, Md. Shahed-Al-Mahmud Life Sciences.2022; 308: 120981. CrossRef
COVID-19 і хвороба Паркінсона I.M. Karaban, T.V. Hasiuk, N.V. Karasevych INTERNATIONAL NEUROLOGICAL JOURNAL.2022; 18(3): 46. CrossRef
The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) has led to a serious global health crisis. Increasing evidence suggests that elderly individuals with underlying chronic diseases, including Parkinson’s disease (PD), are particularly vulnerable to this infection. Changes in the routine care of PD patients should be implemented carefully without affecting the quality provided. The utilization of telemedicine for clinical consultation, assessment and rehabilitation has also been widely recommended. Therefore, the aim of this review is to provide recommendations in the management of PD during the pandemic as well as in the early phase of vaccination programs to highlight the potential sequelae and future perspectives of vaccination and further research in PD. Even though a year has passed since COVID- 19 emerged, most of us are still facing great challenges in providing a continuum of care to patients with chronic neurological disorders. However, we should regard this health crisis as an opportunity to change our routine approach in managing PD patients and learn more about the impact of SARS-CoV-2. Hopefully, PD patients can be vaccinated promptly, and more detailed research related to PD in COVID-19 can still be carried out.
Citations
Citations to this article as recorded by
Increasing exercise with a mobile app in people with Parkinson’s disease: a pilot study Jong Hyeon Ahn, Dongrul Shin, Dongyeong Lee, Hye Young Kim, Jinyoung Youn, Jin Whan Cho, Suzanne Kuys Brain Impairment.2024;[Epub] CrossRef
Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation Hui Li, Junliang Qian, Youcui Wang, Juan Wang, Xiaoqing Mi, Le Qu, Ning Song, Junxia Xie Ageing Research Reviews.2024; 97: 102288. CrossRef
A large survey on COVID-19 vaccination in patients with Parkinson’s disease and healthy population Chao Han, Zhen Zhen Zhao, Piu Chan, Fang Li, Chun Ling Chi, Xin Zhang, Yan Zhao, Jing Chen, Jing Hong Ma Vaccine.2023; 41(43): 6483. CrossRef
Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review Jeremy M. Morowitz, Kaylyn B. Pogson, Daniel A. Roque, Frank C. Church Brain Sciences.2022; 12(5): 536. CrossRef
Deep Learning Paradigm for Cardiovascular Disease/Stroke Risk Stratification in Parkinson’s Disease Affected by COVID-19: A Narrative Review Jasjit S. Suri, Mahesh A. Maindarkar, Sudip Paul, Puneet Ahluwalia, Mrinalini Bhagawati, Luca Saba, Gavino Faa, Sanjay Saxena, Inder M. Singh, Paramjit S. Chadha, Monika Turk, Amer Johri, Narendra N. Khanna, Klaudija Viskovic, Sofia Mavrogeni, John R. Lai Diagnostics.2022; 12(7): 1543. CrossRef
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease Sabrina Poonja, K. Ray Chaudhuri, Janis M. Miyasaki Current Opinion in Neurology.2022; 35(4): 494. CrossRef
Viruses, parkinsonism and Parkinson’s disease: the past, present and future Valentina Leta, Daniele Urso, Lucia Batzu, Yue Hui Lau, Donna Mathew, Iro Boura, Vanessa Raeder, Cristian Falup-Pecurariu, Daniel van Wamelen, K. Ray Chaudhuri Journal of Neural Transmission.2022; 129(9): 1119. CrossRef
A systematic review of the factors associated with the psychological wellbeing of people with Parkinson’s in the COVID-19 pandemic H. Gotheridge, F. J. R. Eccles, C. Murray, R. Henderson, J. Simpson Disability and Rehabilitation.2024; : 1. CrossRef
Differential impact of resilience on demoralization and depression in Parkinson disease John M. de Figueiredo, Boheng Zhu, Amar S. Patel, Robert Kohn, Brian B. Koo, Elan D. Louis Frontiers in Psychiatry.2023;[Epub] CrossRef
Reliability and validity of the novel Italian version of the 14-item Resilience Scale (RS-14) in adults Sofia Cuoco, Immacolata Carotenuto, Arianna Cappiello, Rossella Bisogno, Marina Picillo, Maria Teresa Pellecchia, Paolo Barone, Roberto Erro Neurological Sciences.2022; 43(5): 3079. CrossRef
Neurological manifestations of coronavirus disease (COVID-19) have increasingly been reported since the onset of the pandemic. Herein, we report a relatively new presentation. A patient in the convalescence period following a febrile illness with lower respiratory tract infection (fever, myalgia, nonproductive cough) presented with generalized disabling myoclonus, which is phenotypically suggestive of brainstem origin, along with additional truncal cerebellar ataxia. His neurology work-ups, such as brain MRI, electroencephalography, serum autoimmune and paraneoplastic antibody testing, were normal. His CT chest scan revealed right lower lung infiltrates, and serological and other laboratory testing did not show evidence of active infection. COVID-19 titers turned out to be strongly positive, suggestive of post-COVID-19 lung sequelae. He responded partially to antimyoclonic drugs and fully to a course of steroids, suggesting a para- or postinfectious immune-mediated pathophysiology. Myoclonusataxia syndrome appears to be a neurological manifestation of COVID-19 infection, and knowledge regarding this phenomenon should be increased among clinicians for better patient care in a pandemic situation.
Citations
Citations to this article as recorded by
A case of suspected autoimmune encephalopathy with involuntary movements and cognitive dysfunction post‐COVID‐19 Yosuke Tenpaku, Naoki Mabuchi, Takahiro Kawase, Hideki Oguro, Hiroshi Tatsumi, Masayuki Satoh Psychiatry and Clinical Neurosciences Reports.2024;[Epub] CrossRef
Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2 Josef Finsterer, Fulvio A. Scorza Neuro-Ophthalmology.2023; 47(1): 1. CrossRef
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid Isa Lindqvist, Janet L. Cunningham, Jan Mulder, Amalia Feresiadou, Elham Rostami, Johan Virhammar, Eva Kumlien European Journal of Neurology.2023; 30(10): 3142. CrossRef
Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19 Kenta Osawa, Atsuhiko Sugiyama, Akiyuki Uzawa, Shigeki Hirano, Tatsuya Yamamoto, Masahiko Nezu, Nobuyuki Araki, Hiroki Kano, Satoshi Kuwabara Internal Medicine.2022; 61(7): 1071. CrossRef
Post‐infectious cerebellar ataxia following COVID‐19 in a patient with epilepsy Sidhartha Chattopadhyay, Judhajit Sengupta, Sagar Basu Clinical and Experimental Neuroimmunology.2022; 13(4): 323. CrossRef
Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis Rizaldy Taslim Pinzon, Vincent Ongko Wijaya, Abraham Al Jody, Patrick Nalla Nunsio, Ranbebasa Bijak Buana Journal of Infection and Public Health.2022; 15(8): 856. CrossRef
Anti-neuronal antibodies against brainstem antigens are associated with COVID-19 Guglielmo Lucchese, Antje Vogelgesang, Fabian Boesl, Dina Raafat, Silva Holtfreter, Barbara M. Bröker, Angela Stufano, Robert Fleischmann, Harald Prüss, Christiana Franke, Agnes Flöel eBioMedicine.2022; 83: 104211. CrossRef
Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins Massimiliano Godani, Alessandro Beronio, Giuseppe Lanza Movement Disorders Clinical Practice.2022;[Epub] CrossRef
Spectrum of de novo movement disorders in the setting of COVID-19 infection Mitesh Chandarana, Heli Shah, Soaham Desai Annals of Movement Disorders.2022; 5(1): 23. CrossRef
Anti-GAD associated post-infectious cerebellitis after COVID-19 infection Ahmed Serkan Emekli, Asuman Parlak, Nejla Yılmaz Göcen, Murat Kürtüncü Neurological Sciences.2021; 42(10): 3995. CrossRef
Objective Telemedicine has rapidly gained momentum in movement disorder neurology during the coronavirus disease (COVID-19) pandemic to preserve clinical care while mitigating the risks of in-person visits. We present data from the rapid implementation of virtual visits in a large, academic, movement disorder practice during the COVID-19 pandemic.
Methods We describe the strategic shift to virtual visits and retrospectively examine elements that impacted the ability to switch to telemedicine visits using historical prepandemic in-person data as a comparator, including demographics, distance driven, and diagnosis distribution, with an additional focus on patients with deep brain stimulators.
Results A total of 686 telemedicine visits were performed over a five-week period (60% of those previously scheduled for in-office visits). The average age of participants was 65 years, 45% were female, and 73% were Caucasian. Men were more likely to make the transition (p = 0.02). Telemedicine patients lived farther from the clinic than those seen in person (66.47 km vs. 42.16 km, p < 0.001), age was not associated with making the switch, and patient satisfaction did not change. There was a significant shift in the distribution of movement disorder diagnoses seen by telemedicine compared to prepandemic in-person visits (p < 0.001). Patients with deep brain stimulators were more likely to use telemedicine (11.5% vs. 7%, p < 0.001).
Conclusion Telemedicine is feasible, viable and relevant in the care of movement disorder patients, although health care disparities appear evident for women and minorities. Patients with deep brain stimulators preferred telemedicine in our study. Further study is warranted to explore these findings.
Citations
Citations to this article as recorded by
Interest and Satisfaction of Telemedicine Use Among Ambulatory Neurology Patients in Western North Carolina During the COVID-19 Pandemic K. Alexander Soltany, Reyna Segovia Molina, Carly Pappo, Sharon Thomson, Kelly Pring, Siobhan Cox, Rebecca Merrill, Emily Fishman, Alexander Ambrosini, Gabby Bognet, Kristen Dodenhoff, Heidi Munger Clary, Lauren Strauss, Rachel Graham, Amy K. Guzik, Roy E Telemedicine and e-Health.2024; 30(4): e1071. CrossRef
The Importance of Digital Health Literacy in an Evolving Parkinson’s Disease Care System Christine D. Esper, Blanca Y. Valdovinos, Ruth B. Schneider, Elke Kalbe, Bastiaan R. Bloem, Lorraine V. Kalia, Alice Nieuwboer Journal of Parkinson's Disease.2024; 14(s1): S181. CrossRef
Neurological Examination via Telemedicine: An Updated Review Focusing on Movement Disorders Efthalia Angelopoulou, Christos Koros, Evangelia Stanitsa, Ioannis Stamelos, Dionysia Kontaxopoulou, Stella Fragkiadaki, John D. Papatriantafyllou, Evangelia Smaragdaki, Kalliopi Vourou, Dimosthenis Pavlou, Panagiotis D. Bamidis, Leonidas Stefanis, Sokrat Medicina.2024; 60(6): 958. CrossRef
Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives Andreas Wolfgang Wolff, Bernhard Haller, Antonia Franziska Demleitner, Dominik Pürner, Johanna Niederschweiberer, Isabell Cordts, Erica Westenberg, Paul Lingor Movement Disorders Clinical Practice.2023; 10(5): 819. CrossRef
Telemedicine technologies and applications in the era of COVID-19 pandemic: A systematic review Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Mohammad Heydari, Amirali Karimi, Abdollah Mahdavi, Mehrnaz Mashoufi, Arezoo Sarmad, Peyman Mirghaderi, Ahmadreza Shamsabadi, Kowsar Qaderi, Pegah Mirzapour, Amirata Fakhfouri, Hadiseh Azadi Cheshmekabodi, Kimia Health Informatics Journal.2023; 29(2): 146045822311674. CrossRef
Racial disparities in access to DBS: results of a real-world U.S. claims data analysis Michael Frassica, Drew S. Kern, Mitra Afshari, Allison T. Connolly, Chengyuan Wu, Nathan Rowland, Juan Ramirez-Castaneda, Mwiza Ushe, Claudia Salazar, Xenos Mason Frontiers in Neurology.2023;[Epub] CrossRef
Parkinson’s disease patients’ perspective on telephone visits during the COVID-19 pandemic Marta Magriço, Miguel Serôdio, Rita Ventura, Paulo Bugalho Journal of Neural Transmission.2023; 130(12): 1547. CrossRef
Telemedicine in Neurology: A Scoping Review of Key Outcomes in Movement Disorders Emily Houston, Amanda G. Kennedy, Donna O'Malley, Terry Rabinowitz, Gail L. Rose, James Boyd Telemedicine and e-Health.2022; 28(3): 295. CrossRef
Clinician and patient experience of neurology telephone consultations during the COVID-19 pandemic Tagore Nakornchai, Elena Conci, Anke Hensiek, J William L Brown Postgraduate Medical Journal.2022; 98(1161): 533. CrossRef
Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research B. Y. Valdovinos, J. S. Modica, R. B. Schneider Current Neurology and Neuroscience Reports.2022; 22(2): 113. CrossRef
Movement Disorder Specialists Survey Regarding Use of Telemedicine During the COVID-19 Pandemic Shadi Ghourchian, Yasar A. Torres-Yaghi, Stuart H. Isaacson, Fernando Pagan, Kelly E. Lyons, Brian James Nagle, Sanskruti Patel, Rajesh Pahwa Telemedicine and e-Health.2022; 28(11): 1651. CrossRef
Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study Yaqian Xu, Megan P. Feeney, Matthew Surface, Dan Novak, Michelle S. Troche, James C. Beck, Roy N. Alcalay Movement Disorders.2022; 37(6): 1289. CrossRef
Service process factors affecting patients’ and clinicians’ experiences on rapid teleconsultation implementation in out-patient neurology services during COVID-19 pandemic: a scoping review Guangxia Meng, Carrie McAiney, Christopher M. Perlman, Ian McKillop, Therese Tisseverasinghe, Helen H. Chen BMC Health Services Research.2022;[Epub] CrossRef
Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives Esther Cubo, Pedro David Delgado-López Brain Sciences.2022; 12(12): 1735. CrossRef
Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey Rimal Bera, Morgan Bron, Betsy Benning, Samantha Cicero, Heintje Calara, Diane Darling, Ericha Franey, Kendra Martello, Charles Yonan Neuropsychiatric Disease and Treatment.2022; Volume 18: 2945. CrossRef
COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study Yvonne Teuschl, Christian Bancher, Michael Brainin, Alexandra Dachenhausen, Karl Matz, Michaela M. Pinter Journal of Neural Transmission.2022; 129(1): 49. CrossRef
Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of the drug. We present a case of a 38-year-old male who was started on HCQ for COVID-19 pneumonia. He was referred for evaluation of myoclonus of all extremities, which resolved after discontinuation of HCQ. The involuntary movements were first reported after the initiation of HCQ, persisted despite improvement in inflammatory and radiologic parameters and eventually resolved after HCQ discontinuation. This supports a possible causality related to adverse drug reactions from HCQ that have not been commonly reported.
Citations
Citations to this article as recorded by
Safety profile of COVID-19 drugs in a real clinical setting Mei Nee Chiu, Maitry Bhardwaj, Sangeeta Pilkhwal Sah European Journal of Clinical Pharmacology.2022; 78(5): 733. CrossRef
Eventos adversos no sistema nervoso central potencialmente relacionados aos medicamentos utilizados na COVID-19: revisão de escopo Vinícius de Mello, Vinícius de Paula Pereira, João Paulo Vilela Rodrigues, Suelem Tavares da Silva Penteado, Leonardo Régis Leira Pereira, Fabiana Rossi Varallo Revista Panamericana de Salud Pública.2022; 46: 1. CrossRef
Objective The novel coronavirus disease (COVID-19) pandemic and public health measures to control it have resulted in unique challenges in the management of patients with deep brain stimulation (DBS). We report our experience with the management of acute worsening of symptoms due to battery exhaustion in 3 patients with DBS.
Methods Patients with DBS for movement disorders who visited the emergency room due to battery exhaustion during the nationwide lockdown from April to May 2020 were included.
Results Two patients with subthalamic nucleus-DBS for Parkinson’s disease (PD) and one with globus pallidus interna-DBS for generalized dystonia presented with acute worsening of symptoms due to battery exhaustion. Urgent battery replacement was performed in both patients with PD. The patient with generalized dystonia was managed with medication adjustment as he chose to defer battery replacement.
Conclusion DBS battery replacement can be an emergency. Decisions regarding DBS battery replacement should be individualized during this COVID-19 pandemic.
Citations
Citations to this article as recorded by
Lessons learned during COVID-19 pandemic, a worldwide survey: evolution of global neurosurgical practice Harsh DEORA, Amol RAHEJA, Shashwat MISHRA, Vivek TANDON, Edoardo AGOSTI, Pierlorenzo VEICESCHI, Kanwaljeet GARG, Vikas NAIK, Shweta KEDIA, Rajesh MEENA, Satya S. MUNJAL, Bipin CHAURASIA, Jack WELLINGTON, Davide LOCATELLI, Marco M. FONTANELLA, Manmohan SIN Journal of Neurosurgical Sciences.2024;[Epub] CrossRef
Akinetic crisis and withdrawal syndromes: guideline “Parkinson’s disease” of the German Society of Neurology Monika Pötter-Nerger, Matthias Löhle, Günter Höglinger Journal of Neurology.2024; 271(10): 6485. CrossRef
Deep Brain Stimulation Withdrawal Syndrome, a Rare Life-Threatening Condition in Neurology and Neurosurgery Ekaterina V. Bril, Alexey A. Tomskiy, Anna A. Gamaleya, Anna A. Poddubskaya, Dmytriy G. Kesarev, Natalia V. Fedorova Annals of Clinical and Experimental Neurology.2024; 18(3): 91. CrossRef
Effects of COVID-19 on Synaptic and Neuronal Degeneration Mohammed S. Alqahtani, Mohamed Abbas, Mohammad Y. Alshahrani, Khulud Alabdullh, Amjad Alqarni, Fawaz F. Alqahtani, Layal K. Jambi, Adnan Alkhayat Brain Sciences.2023; 13(1): 131. CrossRef
Needs and Perceptions of Patients With Dystonia During the COVID-19 Pandemic: A Qualitative Framework Analysis of Survey Responses From Italy Vittorio Rispoli, Matías Eduardo Díaz Crescitelli, Francesco Cavallieri, Francesca Antonelli, Stefano Meletti, Luca Ghirotto, Franco Valzania Frontiers in Neurology.2022;[Epub] CrossRef
Movement Disorder Emergencies Ishita Desai, Niraj Kumar Annals of Indian Academy of Neurology.2022; 25(5): 801. CrossRef
Spectrum of Movement Disorder Emergencies in a Tertiary Care Center in India Abhishek P. Bhoyar, Rohan Mahale, Nitish Kamble, Vikram Holla, Pramod Kumar Pal, Ravi Yadav Annals of Indian Academy of Neurology.2022; 25(5): 890. CrossRef
Parkinsonism hyperpyraexia syndrome in Parkinson's disease patients undergoing deep brain stimulation: An indirect consequence of COVID-19 lockdowns Onanong Phokaewvarangkul, Sasivimol Virameteekul, Roongroj Bhidayasiri Parkinsonism & Related Disorders.2021; 87: 39. CrossRef
An Investigation Into Miniaturised Closed-Loop DBS Devices Dean M. Corva, Scott D. Adams, Kevin E. Bennet, Parastoo Hashemi, Michael Berk, Abbas Z. Kouzani IEEE Transactions on Medical Robotics and Bionics.2021; 3(3): 671. CrossRef
Impact of COVID-19 Pandemic on Parkinson's Disease Niraj Kumar, Ravi Gupta Annals of Indian Academy of Neurology.2021; 24(2): 121. CrossRef
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey Carla Piano, Francesco Bove, Tommaso Tufo, Isabella Imbimbo, Danilo Genovese, Alessandro Stefani, Massimo Marano, Antonella Peppe, Livia Brusa, Rocco Cerroni, Francesco Motolese, Enrico Di Stasio, Marianna Mazza, Antonio Daniele, Alessandro Olivi, Paolo C Frontiers in Neurology.2020;[Epub] CrossRef